Partner Article
Salford-based BioClinics gets green light to expand testing
Salford testing firm BioClinics is set for further growth after securing approval to supply its services to several key target markets.
BioClinics conducts its tests by collecting and analysing urine and breath samples. It operates a network of clinics and mobile sample collectors across the UK and Ireland.
The firm has gained accreditations from Achilles Group, which evaluates suppliers on behalf of companies and organisations operating in nearly a dozen sectors.
BioClinics has passed industry audits for its workplace drug and alcohol tests in the transport, rail and utilities sectors.
The accreditations mean BioClinics is now an approved supplier of pre-employment and random tests to the rail and transport sectors, including Network Rail and its sub-contractors, and to utility companies including National Grid and its sub-contractors.
BioClinics experiencing a 470% rise in the number of annual tests it carried out between 2010 and 2013.
Nichola McChrystal, founder and scientific director of BioClinics, said: “We are aiming to double the number of tests we carry out over the next six months. In the longer term, major investment projects such as the HS2 and HS3 rail links should generate even greater demand for our testing services.”
This was posted in Bdaily's Members' News section by Sophia Taha .
How businesses can reduce workplace safety risks with custom solutions
Tech firm unveils jobs plan after £530,000 backing
SMEs urged to think big at Newcastle event
B Corp is a commitment, not a one-time win
Government must get in gear on vehicle transition
A legacy in stone and spirit
Shaping the future: Your guide to planning reforms
The future direction of expert witness services
Getting people into gear for a workplace return
What to expect in the Spring Statement
Sunderland leading way in UK office supply market
Key construction developments in 2025